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OBJECTIVES We sought to examine the age and gender distribution of coronary artery calcium (CAC) by
diabetes status in a large cohort of asymptomatic individuals.
BACKGROUND Among individuals with diabetes, coronary artery disease (CAD) is a major cause of
morbidity and mortality. Electron-beam tomography (EBT) quantifies CAC, a marker for
atherosclerosis.
METHODS Screening for CAC by EBT was performed in 30,904 asymptomatic individuals stratified by
their self-reported diabetes status, gender, and age. The distribution of CAC across the strata
and the association between diabetes and CAC were examined.
RESULTS Compared with nondiabetic individuals (n  29,829), those with diabetes (n  1,075) had
higher median CAC scores across all but two age groups (women 40 to 44 years old and men
and women 70 years old). Overall, the likelihood of having a CAC score in the highest
age/gender quartile was 70% greater for diabetic individuals than for their nondiabetic
counterparts.
CONCLUSIONS Younger diabetic individuals appear to have calcified plaque burden comparable to that of
older individuals without diabetes. These findings call for future research to determine if
EBT-CAC screening has an incremental value over the current CAD risk assesment of
individuals with diabetes. (J Am Coll Cardiol 2003;41:1008–12) © 2003 by the American
College of Cardiology Foundation
Approximately 10.3 million Americans have physician-
diagnosed diabetes, whereas an estimated 5.4 million people
are undiagnosed (1). Cardiovascular complications are the
major cause of diabetes-associated morbidity and mortality,
as two-thirds of people with diabetes die of heart or blood
vessel disease (2–4).
Routine assessment of conventional risk factors accounts
for only a portion of the increased coronary artery disease
(CAD) risk observed among diabetic individuals (5).
Electron-beam tomography (EBT) is a noninvasive tool for
the detection and quantification of coronary artery calcium
(CAC), a marker for atherosclerosis. The extent of CAC
strongly correlates with the overall magnitude of atheroscle-
rotic plaque burden (6) and with the development of
subsequent coronary events (7,8). Previously published re-
ports have demonstrated, in limited samples of diabetic
individuals, greater calcified plaque burden by EBT, as
compared with nondiabetic individuals (9–12). The present
study supplements the existing reports of the association
between EBT-CAC and diabetes by examining the age and
gender distribution of CAC in a large cohort of asymptom-
atic diabetic and nondiabetic individuals.
METHODS
Study sample. Between 1993 and 1999, 32,477 individuals
(30 to 90 years old) were self-referred for EBT CAC
screening. Before screening, subjects completed a question-
naire eliciting demographic and CAD risk factor informa-
tion. Of these individuals, 1,573 were excluded from this
analysis because of a history of clinical CAD. The Univer-
sity of Illinois at Chicago (UIC) Internal Review Board
approved the study protocol.
Self-reported CAD risk factors included a history of
smoking, diabetes, hypercholesterolemia, hypertension, and
a family history of CAD. The definitions of self-reported
CAD risk factors have been reported previously (13). The
validity of self-reported histories of hypercholesterolemia,
diabetes, and hypertension was examined in a peripheral
study (14). The kappa coefficients for hypercholesterolemia,
diabetes, and hypertension were 0.796 (p  0.001), 0.783
(p  0.001), and 0.36 (p  0.01), respectively. The
incongruity observed for hypertension was mainly due to an
abundance of individuals previously diagnosed with hyper-
tension whose high blood pressure was controlled with
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life-style modification and who presented with normal
blood pressure at the time of examination.
Electron-beam tomography. The EBT-CAC scans were
obtained using a C-100 or C-150 scanner (GE Imatron,
South San Francisco, California). Using electrocardio-
graphic triggering at 60% to 80% of the ECG RR interval,
two sets of 100-ms/3-mm images (40 and 20 slices) were
acquired. The CAC score was calculated using the Agatston
method (15). The details of the UIC scanning protocol have
been published elsewhere (13).
Data analysis. The study sample was stratified by gender
and into eight exclusive five-year age groups (from 40 to
70 years old). Analysis was conducted using SPSS version
10.0 for Windows (SPSS, Inc., Chicago, Illinois). The
Mann-Whitney U test was used to compare median CAC
scores between diabetic and nondiabetic individuals by age
group. Chi-square analysis was used to compare the preva-
lence of risk factors and CAC. Controlling for age and body
mass index, a multivariable logistic regression analysis was
used to examine the association between CAD risk factors
and CAC scores 75th percentile for age/gender (13).
RESULTS
Sample characteristics. The study sample consisted of
22,188 men and 8,716 women (30 to 90 years old). Diabetes
was reported by 747 of the men (3.4%) and 328 of the
women (3.8%). Demographics, risk factors, and CAC
characteristics for the study sample stratified by gender and
diabetes status are summarized in Table 1. Generally,
diabetic individuals were older and had a greater prevalence
of hypertension, cigarette use, and CAC, as compared with
those without diabetes. Overall, the mean (SD) total
CAC score in the diabetic group was 284  684, as
compared with 106  328 in those without diabetes. The
reported socioeconomic indicators (income and education)
for both the diabetic and nondiabetic individuals were
higher than the national averages. Despite the high socio-
economic status of the study sample, the under-
representation of women and minorities, and the use of
self-referred individuals, the prevalence figures for CAD
risk factors in the present study sample were similar to
Abbreviations and Acronyms
ARIC  atherosclerosis Risk in Communities Study
CAC  coronary artery calcium
CAD  coronary artery disease
EBT  electron-beam tomography
NHANES  National Health And Nutrition Education
Survey
UIC  University of Illinois at Chicago
Table 1. Demographics, Risk Factors, and CAC Characteristics of Men and Women With and
Without Diabetes
Men Diabetes (n  747) No Diabetes (n  21,441) p Value
Mean age (yrs) 55  9 50  9  0.001
Annual income $50,000 82 74 0.001
Education 12 years 94 97 0.002
Family history of CAD 52 52 0.84
Past or current smoking 62 51  0.001
Hypertension 47 20  0.001
Hypercholesterolemia 37 36 0.68
Mean body mass index (kg/m2) 30  5 28  4  0.001
Presence of CAC (0) 90 77  0.001
Mean CAC score 346  749 127  359  0.001
Median CAC score (interquartile range) 63 (5–365) 6 (1–80)  0.001
Total CAC 75% age/gender percentile 39 24  0.001
Women Diabetes (n  328) No Diabetes (n  8,388) p Value
Mean age (yrs) 56  10 54  9  0.001
Annual income $50,000 56 67  0.001
Education 12 years 85 95  0.001
Family history of CAD 57 56 0.73
Past or current smoking 49 47 0.52
Hypertension 55 22  0.001
Hypercholesterolemia 36 39 0.26
Mean body mass index (kg/m2) 31  6 27  5  0.001
Presence of CAC (0) 75 53  0.001
Mean CAC score 142  479 52  219  0.001
Median CAC score (interquartile range) 5 (0–104) 1 (0–11)  0.001
Total CAC 75% age/gender
percentile
40 23  0.001
Differences between diabetic and nondiabetic individuals were examined using the Pearson’s chi-square test (for percentages),
independent samples t test (for age, body mass index, and mean CAC score), and Mann-Whitney U test (for median CAC
score). Data are presented as the mean value  SD or percentage of subjects.
CAC  coronary artery calcium; CAD  coronary artery disease.
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estimates for the general U.S. population, using data from
the National Health And Nutrition Education Survey
(NHANES) and the Atherosclerosis Risk in Communities
(ARIC) study (16,17). Table 2 provides pairwise compari-
sons of median CAC scores by gender, age, and diabetes
status. Compared with nondiabetic subjects, men and
women with diabetes exhibited higher CAC scores across
all ages, with the exception of women 40 to 44 years of age
and men and women 70 years of age. Within each
five-year age group, diabetic men exhibited consistently
higher CAC scores than did diabetic women (p 0.001 for
all comparisons), except for the youngest age group (subjects
40 years old; p  0.05). Table 3 provides the results of a
logistic regression analysis examining the association be-
tween CAD risk factors and a total CAC score in the
highest age/gender quartile. For both genders, every CAD
risk factor was significantly associated with a total CAC
score in the highest age/gender quartile. Diabetes was the
strongest predictor for having a CAC score in the highest
quartile for both genders. Overall, the likelihood of having
a CAC score in the highest age/gender quartile was 70%
greater for diabetic individuals than for their nondiabetic
counterparts.
Among men and women, an association between age and
the extent of CAC has been demonstrated previously (13).
As diabetic individuals were significantly older than their
nondiabetic counterparts, the age-adjusted multivariable
logistic regression analysis described previously was repeated
Table 2. Median CAC Scores of Men and Women With and Without Diabetes
Men
Diabetes No Diabetes
p Valuen
Median CAC
Score n
Median CAC
Score
Age group (years)
40 46 4 3,005 1  0.001
40–44 63 13 3,653 1  0.001
45–49 100 9.5 4,322 3 0.001
50–54 144 42 4,142 14  0.001
55–59 160 111 2,912 43  0.001
60–64 117 192 1,860 105  0.001
65–69 72 378 955 152  0.001
70 45 343 592 301 0.77
Total 747 63 21,441 6  0.001
Women
Diabetes No Diabetes
p Valuen
Median CAC
Score n
Median CAC
Score
Age group (years)
40 21 1 514 0  0.001
40–44 32 0 846 0 0.14
45–49 32 1 1,398 0 0.01
50–54 74 8.5 1,826 0  0.001
55–59 52 7.5 1,522 1  0.001
60–64 47 21 1,105 2 0.003
65–69 34 104 712 5 0.006
70 36 114 465 52 0.54
Total 328 5 8,388 1  0.001
The Mann-Whitney U test was used to compare coronary artery calcium (CAC) scores between diabetic and nondiabetic subjects
within each five-year age group. The analyses were performed separately for men and women.
Table 3. Association Between CAD Risk Factors and the Highest Age and Gender Quartile of
Coronary Artery Calcium Score ( 75%) Among Men and Women (n  30,904)
Men Women
Odds Ratio p Value Odds Ratio p Value
Age (yrs) 1.001 (0.99–1.004) 0.77 0.998 (0.992–1.003) 0.41
Body mass index (kg/m2) 1.04 (1.03–1.05)  0.001 1.05 (1.04–1.06)  0.001
Family history of CAD (yes/no) 1.19 (1.11–1.27)  0.001 1.16 (1.04–1.29) 0.01
Hypercholesterolemia (yes/no) 1.23 (1.15–1.32)  0.001 1.39 (1.24–1.55)  0.001
Cigarette use (yes/no) 1.36 (1.27–1.45)  0.001 1.57 (1.41–1.75)  0.001
Hypertension (yes/no) 1.41 (1.31–1.53)  0.001 1.51 (1.33–1.71)  0.001
Diabetes (yes/no) 1.73 (1.47–2.03)  0.001 1.69 (1.32–2.16)  0.001
The logistic regression model was constructed using block entry of all predictor variables. The analyses were performed separately
for men and women.
CAD  coronary artery disease.
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using a 3-to-1 age/gender frequency-matched sample of
3,225 randomly selected nondiabetic control subjects. In
this model, the associations between CAD risk factors and
a total CAC score 75th percentile for age/gender were
very similar to those reported for the unmatched sample,
with the exception of cigarette use and hypercholesterolemia
in men in whom the magnitude of risk was similar but the
significance at the 0.05 level was lost.
DISCUSSION
Electron-beam tomography is gaining acceptance as a tool
for the detection of subclinical CAD and for guiding
diagnostic and treatment strategies (18). This study reports
the distribution of CAC in a large sample of diabetic men
and women without known CAD. Our findings demon-
strate that asymptomatic diabetic men and women have
higher median CAC scores than do their nondiabetic
counterparts, with a few exceptions. For women 40 to 44
years of age and men and women70 years of age, the most
probable explanation for the lack of a difference in EBT-
CAC median scores by diabetes status is a lack of power
resulting from the small number of individuals in each
group. It is also possible that the older diabetic individuals
in this study were long-term, well-controlled survivors or
possibly newly diagnosed with diabetes. Another finding
was that among subjects with diabetes at any given age, men
exhibited significantly greater calcified plaque burden, as
compared with women.
Among the CAD risk factors examined, diabetes was the
strongest correlate for a CAC score in the highest age-
specific quartile for both genders, even when using an
age/gender-matched sample of nondiabetic control subjects.
The use of EBT for the detection of CAD in diabetic
individuals has been studied previously. In a recent study,
Schurgin et al. (9) examined the degree of CAC in a sample
of 139 asymptomatic diabetic individuals, as compared with
the randomly selected nondiabetic group. Among diabetic
subjects, 26% had scores 400, compared with 7.2% in the
randomly selected nondiabetic group. Another group of
researchers (Olson et al. [10]) found that CAC had 84%
sensitivity for clinical CAD in type I diabetic men and 71%
sensitivity in type I diabetic women. Khaleeli et al. (11)
determined that 168 symptomatic (anginal) diabetic indi-
viduals had a higher prevalence of CAC, as compared with
155 asymptomatic diabetic individuals. Interestingly, no
significant difference was determined between diabetic men
and women with regard to CAC scores at any given age.
The failure to show a significant difference, however, could
be attributable to the small sample size (n  323) and the
small correlation coefficients (r 0.28 for men and r 0.36
for women) reported.
There are some limitations of the present study, which
will be addressed in future research. The CAD risk factors
were assessed using self-reporting, with no clinical measure-
ment. Yet, in a peripheral study, we found high levels of
agreement between self-reported and clinically measured
diabetes status (14). In addition, all study subjects were
self-referred, and there is a concern that self-referred indi-
viduals may represent extremes of the population relative to
health status. In considering these limitations, it is impor-
tant to note that the prevalence rates for CAD risk factors
in the study sample were comparable to those reported in
two population-based studies (16,17). Also, one-third of
type II diabetes is undiagnosed (19). It is quite possible that
there were individuals with impaired glucose tolerance or
type II diabetes who were categorized as nondiabetic. In
light of this limitation, the observed differences by diabetes
status would be attenuated, and therefore it is possible that
the differences between diabetic and nondiabetic individuals
are greater than we report.
The clinical utility of noninvasive evaluation of athero-
sclerosis in asymptomatic diabetic individuals remains un-
clear. Because diabetes places individuals in the same risk
category as individuals with known CAD (2), noninvasive
testing such as EBT-CAC screening would do little to
change the current clinical management of traditional car-
diovascular risk factors. Yet future studies to determine
whether CAC scores predict future clinical events in asymp-
tomatic individuals with diabetes will help delineate a role
for EBT in the clinical management of diabetes (20).
The increasing use of imaging modalities in population-
based studies and clinical practice may enhance the utility of
CAC screening, which could be an important tool in
describing the natural history of coronary atherosclerosis in
both impaired glucose tolerance and diabetes. Among pre-
diabetic individuals, especially those with the metabolic
syndrome, CAC screening could be particularly useful in the
stratification of certain individuals into more aggressive risk
factor management regimens. In addition, EBT-CAC
screening results may potentially motivate individuals in
their CAD risk reduction efforts. Further studies are needed
to address these potential uses of CAC screening.
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